Global Famciclovir API Market Size, Share, Trends and Forecast 2022-2030

Description

Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)
Industry Insights

Due to the COVID-19 pandemic, the global Famciclovir API market size is estimated to be worth US$ 13 million in 2021 and is forecast to a readjusted size of US$ 15 million by 2028 with a CAGR of 2.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Famciclovir API market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Famciclovir API landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.

Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.

Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.

Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report focuses on Famciclovir API volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Famciclovir API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and India, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Famciclovir API market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Insourced

Outsourced

Others

Segment by Application

Tablet Product

Capsule Product

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Chongqing Shenghuaxi Pharma

Aurobindo Pharma Limited

Apotex Pharmachem

Changzhou Kony Pharma Co

Teva Pharmaceutical Industries

Olon

Fuan Pharmaceutical

Zhejiang Charioteer Pharmaceutical

Jialin Pharmaceutical

Zhejiang Hisun

Hetero

TABLE OF CONTENT

1 Famciclovir API Market Overview
1.1 Product Overview and Scope of Famciclovir API

1.2 Famciclovir API Segment by Type

1.2.1 Global Famciclovir API Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Insourced

1.2.3 Outsourced

1.2.4 Others

1.3 Famciclovir API Segment by Application

1.3.1 Global Famciclovir API Sales Comparison by Application: (2022-2028)

1.3.2 Tablet Product

1.3.3 Capsule Product

1.3.4 Others

1.4 Global Famciclovir API Market Size Estimates and Forecasts

1.4.1 Global Famciclovir API Revenue 2017-2028

1.4.2 Global Famciclovir API Sales 2017-2028

1.4.3 Famciclovir API Market Size by Region: 2017 Versus 2021 Versus 2028

2 Famciclovir API Market Competition by Manufacturers

2.1 Global Famciclovir API Sales Market Share by Manufacturers (2017-2022)

2.2 Global Famciclovir API Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Famciclovir API Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Famciclovir API Manufacturing Sites, Area Served, Product Type

2.5 Famciclovir API Market Competitive Situation and Trends

2.5.1 Famciclovir API Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Famciclovir API Players Market Share by Revenue

2.5.3 Global Famciclovir API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Famciclovir API Retrospective Market Scenario by Region

3.1 Global Famciclovir API Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Famciclovir API Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Famciclovir API Market Facts & Figures by Country

3.3.1 North America Famciclovir API Sales by Country

3.3.2 North America Famciclovir API Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Famciclovir API Market Facts & Figures by Country

3.4.1 Europe Famciclovir API Sales by Country

3.4.2 Europe Famciclovir API Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Famciclovir API Market Facts & Figures by Region

3.5.1 Asia Pacific Famciclovir API Sales by Region

3.5.2 Asia Pacific Famciclovir API Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Famciclovir API Market Facts & Figures by Country

3.6.1 Latin America Famciclovir API Sales by Country

3.6.2 Latin America Famciclovir API Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Famciclovir API Market Facts & Figures by Country

3.7.1 Middle East and Africa Famciclovir API Sales by Country

3.7.2 Middle East and Africa Famciclovir API Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Famciclovir API Historic Market Analysis by Type

4.1 Global Famciclovir API Sales Market Share by Type (2017-2022)

4.2 Global Famciclovir API Revenue Market Share by Type (2017-2022)

4.3 Global Famciclovir API Price by Type (2017-2022)

5 Global Famciclovir API Historic Market Analysis by Application

5.1 Global Famciclovir API Sales Market Share by Application (2017-2022)

5.2 Global Famciclovir API Revenue Market Share by Application (2017-2022)

5.3 Global Famciclovir API Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Chongqing Shenghuaxi Pharma

6.1.1 Chongqing Shenghuaxi Pharma Corporation Information

6.1.2 Chongqing Shenghuaxi Pharma Description and Business Overview

6.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Chongqing Shenghuaxi Pharma Famciclovir API Product Portfolio

6.1.5 Chongqing Shenghuaxi Pharma Recent Developments/Updates

6.2 Aurobindo Pharma Limited

6.2.1 Aurobindo Pharma Limited Corporation Information

6.2.2 Aurobindo Pharma Limited Description and Business Overview

6.2.3 Aurobindo Pharma Limited Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Aurobindo Pharma Limited Famciclovir API Product Portfolio

6.2.5 Aurobindo Pharma Limited Recent Developments/Updates

6.3 Apotex Pharmachem

6.3.1 Apotex Pharmachem Corporation Information

6.3.2 Apotex Pharmachem Description and Business Overview

6.3.3 Apotex Pharmachem Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Apotex Pharmachem Famciclovir API Product Portfolio

6.3.5 Apotex Pharmachem Recent Developments/Updates

6.4 Changzhou Kony Pharma Co

6.4.1 Changzhou Kony Pharma Co Corporation Information

6.4.2 Changzhou Kony Pharma Co Description and Business Overview

6.4.3 Changzhou Kony Pharma Co Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Changzhou Kony Pharma Co Famciclovir API Product Portfolio

6.4.5 Changzhou Kony Pharma Co Recent Developments/Updates

6.5 Teva Pharmaceutical Industries

6.5.1 Teva Pharmaceutical Industries Corporation Information

6.5.2 Teva Pharmaceutical Industries Description and Business Overview

6.5.3 Teva Pharmaceutical Industries Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Teva Pharmaceutical Industries Famciclovir API Product Portfolio

6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.6 Olon

6.6.1 Olon Corporation Information

6.6.2 Olon Description and Business Overview

6.6.3 Olon Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Olon Famciclovir API Product Portfolio

6.6.5 Olon Recent Developments/Updates

6.7 Fuan Pharmaceutical

6.6.1 Fuan Pharmaceutical Corporation Information

6.6.2 Fuan Pharmaceutical Description and Business Overview

6.6.3 Fuan Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Fuan Pharmaceutical Famciclovir API Product Portfolio

6.7.5 Fuan Pharmaceutical Recent Developments/Updates

6.8 Zhejiang Charioteer Pharmaceutical

6.8.1 Zhejiang Charioteer Pharmaceutical Corporation Information

6.8.2 Zhejiang Charioteer Pharmaceutical Description and Business Overview

6.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Zhejiang Charioteer Pharmaceutical Famciclovir API Product Portfolio

6.8.5 Zhejiang Charioteer Pharmaceutical Recent Developments/Updates

6.9 Jialin Pharmaceutical

6.9.1 Jialin Pharmaceutical Corporation Information

6.9.2 Jialin Pharmaceutical Description and Business Overview

6.9.3 Jialin Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Jialin Pharmaceutical Famciclovir API Product Portfolio

6.9.5 Jialin Pharmaceutical Recent Developments/Updates

6.10 Zhejiang Hisun

6.10.1 Zhejiang Hisun Corporation Information

6.10.2 Zhejiang Hisun Description and Business Overview

6.10.3 Zhejiang Hisun Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Zhejiang Hisun Famciclovir API Product Portfolio

6.10.5 Zhejiang Hisun Recent Developments/Updates

6.11 Hetero

6.11.1 Hetero Corporation Information

6.11.2 Hetero Famciclovir API Description and Business Overview

6.11.3 Hetero Famciclovir API Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Hetero Famciclovir API Product Portfolio

6.11.5 Hetero Recent Developments/Updates

7 Famciclovir API Manufacturing Cost Analysis

7.1 Famciclovir API Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Famciclovir API

7.4 Famciclovir API Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Famciclovir API Distributors List

8.3 Famciclovir API Customers

9 Famciclovir API Market Dynamics

9.1 Famciclovir API Industry Trends

9.2 Famciclovir API Market Drivers

9.3 Famciclovir API Market Challenges

9.4 Famciclovir API Market Restraints

10 Global Market Forecast

10.1 Famciclovir API Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Famciclovir API by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Famciclovir API by Type (2023-2028)

10.2 Famciclovir API Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Famciclovir API by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Famciclovir API by Application (2023-2028)

10.3 Famciclovir API Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Famciclovir API by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Famciclovir API by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample